During recent testimony before the Senate Health, Education, Labor and Pension Committee hearing on Stabilizing the Affordable Care Act Marketplace, AARP became the largest consumer organization to publicly support the prescription drug policy solutions reflected in Prescription Justice’s policy platform. AARP supports commonsense policy reforms to allow Medicare to negotiate drug prices, end pay-for-delay deals that delay entry of generic drugs into the marketplace, and increase access to lower cost medications through safe prescription drug importation. As part of a larger set of priorities for protecting and strengthening the healthcare system, AARP boldly declared that any changes to the healthcare law must include solutions to address rising prescription drug costs. (more…)
The U.S. Centers for Disease Control and Prevention (CDC) - Public Health Grand Rounds – recently hosted a webinar on “Overcoming Barriers to Medication Adherence for Chronic Diseases.”The event brought together a panel of leaders in pharmacy, nursing, medicine, academia, and public health to discuss the burden of medication nonadherence and barriers for adherence among patients with chronic diseases—including HIV/AIDS.
Medication nonadherence manifests in two distinct behaviors: intentional, such as choosing to forgo filling a prescription because of cost, or unintentional, where patients simply forget to take their medication or are unable to manage multiple medications or complex treatment regimens. The panelists highlighted how intervention strategies aimed at medication adherence can positively affect patient health outcomes. (more…)